×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FHTX – foghorn therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FHTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
07:01 pm
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
11/25
07:00 am
fhtx
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Medium
Report
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
11/17
06:19 am
fhtx
4D Molecular Therapeutics taps Kristian Humer as CFO [Seeking Alpha]
Low
Report
4D Molecular Therapeutics taps Kristian Humer as CFO [Seeking Alpha]
11/17
06:13 am
fhtx
4DMT Appoints Kristian Humer as Chief Financial Officer [Yahoo! Finance]
Low
Report
4DMT Appoints Kristian Humer as Chief Financial Officer [Yahoo! Finance]
11/7
08:45 am
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
11/6
01:21 pm
fhtx
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (NASDAQ:FHTX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
11/5
09:40 pm
fhtx
Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative [Yahoo! Finance]
Low
Report
Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
07:00 am
fhtx
Form 8-K Foghorn Therapeutics For: Dec 03
Low
Report
Form 8-K Foghorn Therapeutics For: Dec 03
11/17
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Nov 14 Filed by: Humer Kristian
Medium
Report
Form 4 Foghorn Therapeutics For: Nov 14 Filed by: Humer Kristian
11/7
04:34 pm
fhtx
Form 8-K Foghorn Therapeutics For: Nov 07
Low
Report
Form 8-K Foghorn Therapeutics For: Nov 07
11/5
07:04 am
fhtx
Form 10-Q Foghorn Therapeutics For: Sep 30
High
Report
Form 10-Q Foghorn Therapeutics For: Sep 30
11/5
07:03 am
fhtx
Form 8-K Foghorn Therapeutics For: Nov 05
High
Report
Form 8-K Foghorn Therapeutics For: Nov 05
10/30
07:27 am
fhtx
Form 8-K Foghorn Therapeutics For: Oct 30
Low
Report
Form 8-K Foghorn Therapeutics For: Oct 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: